Evidence map›Paper›PMID 25156000›Full record

ArticleEnvironmental and molecular mutagenesis2015

Genetic variation in arsenic (+3 oxidation state) methyltransferase (AS3MT), arsenic metabolism and risk of basal cell carcinoma in a European population.

Karin S Engström, Marie Vahter, Tony Fletcher, Giovanni Leonardi, Walter Goessler, Eugen Gurzau, Kvetoslava Koppova, Peter Rudnai, Rajiv Kumar, Karin Broberg

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Environmental and molecular mutagenesis, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Update of the risk assessment of inorganic arsenic in food.EFSA journal. European Food Safety Authority · 2024
    Article
  7. Article
  8. Review
  9. Review
  10. Rare, Protein-Altering Variants inEnvironmental health perspectives · 2021
    Article
  11. Factors Affecting Arsenic Methylation in Contaminated Italian Areas.International journal of environmental research and public health · 2020
    Article
  12. Article
  13. Article
  14. Review
  15. Effects of arsenic toxicity beyond epigenetic modifications.Environmental geochemistry and health · 2018
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 7 countries.

Karin S EngströmDivision of Occupational and Environmental Medicine, Lund University, Lund, Sweden.
Marie Vahter
Tony Fletcher
Giovanni Leonardi
Walter Goessler
Eugen Gurzau
Kvetoslava Koppova
Peter Rudnai
Rajiv Kumar
Karin Broberg
London School of Hygiene & Tropical Medicine · GBLund University · SEBabeș-Bolyai University · ROGerman Cancer Research Center · DEKarolinska Institutet · SEOrszagos Kornyezetegeszsegugyi Intezet · HUPublic Health Authority of the Slovak Republic · SKUniversity of Graz · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exposure to inorganic arsenic increases the risk of basal cell carcinoma (BCC). Arsenic metabolism is a susceptibility factor for arsenic toxicity, and specific haplotypes in arsenic (+3 oxidation state) methyltransferase (AS3MT) have been associated with increased urinary fractions of the most toxic arsenic metabolite, methylarsonic acid (MMA). The aim of this study is to elucidate the association of AS3MT haplotypes with arsenic metabolism and the risk of BCC. Four AS3MT polymorphisms were genotyped in BCC cases (N = 529) and controls (N = 533) from Eastern Europe with low to moderate arsenic exposure (lifetime average drinking water concentration: 1.3 µg/L, range 0.01-167 µg/L). Urinary metabolites [inorganic arsenic (iAs), MMA, dimethylarsinic acid (DMA)] were analyzed by HPLC-ICPMS. Five AS3MT haplotypes (based on rs3740400 A/C, rs3740393 G/C, rs11191439 T/C and rs1046778 T/C) had frequencies >5%. Individuals with the CCTC haplotype had lower %iAs (P = 0.032) and %MMA (P = 0.020) in urine, and higher %DMA (P = 0.033); individuals with the CGCT haplotype had higher %MMA (P < 0.001) and lower %DMA (P < 0.001). All haplotypes showed increased risk of BCC with increasing arsenic exposure through drinking water (ORs 1.1-1.4, P values from <0.001 to 0.082), except for the CCTC haplotype (OR 1.0, CI 0.9-1.2, P value 0.85). The results suggest that carriage of AS3MT haplotypes associated with less-efficient arsenic methylation, or lack of AS3MT haplotypes associated with a more-efficient arsenic methylation, results in higher risk of arsenic-related BCC. The fact that AS3MT haplotype status modified arsenic metabolism, and in turn the arsenic-related BCC risk, supports a causal relationship between low-level arsenic exposure and BCC.

Indexed as

AdultAgedAged, 80 and overArsenicBasal Cell CarcinomaCase-Control StudiesEuropeFemaleFollow-Up StudiesGenotypeHaplotypesHumansMaleMethyltransferasesMiddle AgedPolymerase Chain ReactionArsenicAS3MT protein, humanMethyltransferasesdimethylarsinic acidmetabolismmethylarsonic acidpolymorphism

Identifiers

PMID25156000
PMCPMC4322484
OpenAlexW1857895316

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.